GUEST:On Feb. 19, the U.S. Food and Drug Administration took a huge step towards patient-centric medicine when it approved the marketing of genetics testing company 23andMe’s carrier test for Bloom Syndrome. This was a startling — and good — development because it affirmed the rights of consumers to drive their own health-care decisions and procedures.

NEXT
Topics:  guest   feb   u.s food   drug administration   syndrome   tay–sachs   apple   google   ibm   microsoft    the fda   silicon valley   anne wojicki   canada   big pharma   d.j patil   personal dna   exponential era   vivek wadhwa   rock center   corporate governance   stanford   entrepreneurship   research commercialization   duke   singularity   harvard law school   california berkeley   emory   i   fda   dna   wojicki   patil   university   health   tech   good   data   consumers   tests   hand   safeguards   costs   means   future   cheap   key   people   smart   false   step   test   company   today   regulatory   process   common   part   lack   cancer   breast   care   fellow   named   large   
BING NEWS:
  • Fake Botox probe to be conducted by CDC, FDA after 19 reports of bad reactions in 9 states
    and local health departments to investigate reactions to the injections. Fake Botox probe to be conducted by CDC, FDA after 19 reports of bad reactions in 9 states Weight loss drugs may work for ...
    04/16/2024 - 7:13 am | View Link
  • More

 

NEXT
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

Movies With Butter More Movie News

More Business News